HAP Trading’s Regenxbio RGNX Stock Holding History

HAP Trading’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,600	Closed	-$39K	–	2808
2021 Q3	$39K	Buy	+17,600	New	+$633K	﹤0.01%	1592
2021 Q1	–	Sell	-24,100	Closed	-$76K	–	2265
2020 Q4	$76K	Buy	+24,100	New	+$842K	﹤0.01%	1276

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's RGNX Position: Q3 2019 in Review

HAP Trading sold out of Regenxbio (RGNX) in Q3 2019, closing a stake of 10,376 shares — an estimated $533K sold.

HAP Trading first reported a position in RGNX in Q2 2019 and held it in 1 quarter. The position peaked at $533K in Q2 2019. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

HAP Trading reported no remaining Regenxbio position as of Q3 2019 after selling out during the quarter.
HAP Trading sold 10,376 Regenxbio shares in Q3 2019, an estimated $533K.
HAP Trading first reported a position in Regenxbio in Q2 2019 and held it in 1 quarter.
HAP Trading's Regenxbio position peaked at $533K in Q2 2019.
168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.